Get the Stockscreener App
5.73
4.37%
+0.24
After Hours:
5.95
0.22
+3.84%
Foghorn Therapeutics Inc Stock (FHTX) Forecast
The Foghorn Therapeutics Inc (FHTX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $5.23, representing a -8.73% decrease from the current price of $5.73. The highest analyst price target is $7.8734, and the lowest is $2.5865.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month FHTX Price Target
Average 8.4928
(+48.22% Upside)
Is Foghorn Therapeutics Inc (FHTX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 45.07 | Neutral |
| STOCH(9,6) | 19.56 | Buy |
| STOCHRSI(14) | 33.40 | Neutral |
| MACD(12,26) | -0.3353 | Sell |
| ADX(14) | 15.14 | Neutral |
| William %R | -71.38 | Neutral |
| CCI(14) | -25.05 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
5.451
Buy
|
5.6526
Buy
|
| MA20 |
6.3329
Sell
|
5.9771
Sell
|
| MA50 |
6.4866
Sell
|
6.0879
Sell
|
| MA100 |
5.749
Sell
|
5.8927
Sell
|
| MA200 |
5.8558
Sell
|
5.8851
Sell
|
Buy: 2
Sell: 8
Neutral: 0
Summary: Sell
According to our latest analysis, FHTX could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 9 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on FHTX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 45.07 indicates that FHTX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 19.56 indicates that FHTX is oversold. This indicates that FHTX price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 33.4 indicates that FHTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 15.14 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -25.05 indicates that FHTX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term FHTX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Foghorn Therapeutics Inc financial reports and earnings history, Foghorn Therapeutics Inc (FHTX) stock could reach $2.445 by 2030, $19.00 by 2040 and $49.16 by 2050. See the projected annual prices until 2050 of the Foghorn Therapeutics Inc stock below:
- Foghorn Therapeutics Inc (FHTX) is expected to reach an average price of $23.45 in 2035, with a high prediction of $22.28 and a low estimate of $23.37. This indicates an $309.33% rise from the last recorded price of $5.73.
- Foghorn Therapeutics Inc (FHTX) stock is projected to chart a bullish course in 2040, with an average price target of $18.27, representing an $218.79% surge from its current level. The forecast ranges from a conservative $18.54 to a sky-high $19.00.
- Our analysts predict Foghorn Therapeutics Inc (FHTX) to jump 262.32% by 2045, soaring from $21.39 to an average price of $20.76, potentially reaching $21.57. While $21.39 is the low estimate, the potential upside is significant.
- Foghorn Therapeutics Inc (FHTX) stock is expected to climb by 2050, reaching an average of $42.49, a $641.55% jump from its current level. However, a wide range of estimates exists, with high and low targets of $49.16 and $41.13, respectively, highlighting the market's uncertainty.
Foghorn Therapeutics Inc Stock (FHTX) Year by Year Forecast
Foghorn Therapeutics Inc Stock (FHTX) Price Forecast for 2024
Our forecast for FHTX stock price in 2024 now indicates an average price target of $9.5005 with a high forecast of $18.79 and a low forecast of $0.2133. The average prediction reflects an increase of +65.80% from the last recorded price of $5.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2024 | $4.1802 | $2.5865 | $7.8734 | -27.05% |
| June, 2024 | $2.7975 | $0.9725 | $4.7938 | -51.18% |
| July, 2024 | $1.6966 | $0.4648 | $3.1993 | -70.39% |
| August, 2024 | $1.7039 | $0.7021 | $3.7821 | -70.26% |
| September, 2024 | $1.2431 | $0.5513 | $2.913 | -78.31% |
| October, 2024 | $2.0304 | $0.2133 | $2.6604 | -64.57% |
| November, 2024 | $5.7477 | $1.7422 | $6.3085 | +0.31% |
| December, 2024 | $5.2568 | $3.9095 | $7.4802 | -8.26% |
Foghorn Therapeutics Inc Stock (FHTX) Price Forecast for 2025
Foghorn Therapeutics Inc Stock (FHTX) is expected to reach an average price of $8.9416 in 2025, with a high prediction of $16.77 and a low estimate of $1.1108. This indicates an +56.05% rise from the last recorded price of $5.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $5.9241 | $3.7605 | $6.1741 | +3.39% |
| February, 2025 | $3.8114 | $3.2414 | $6.806 | -33.48% |
| March, 2025 | $15.27 | $2.6033 | $16.25 | +166.50% |
| April, 2025 | $6.5579 | $5.2054 | $16.77 | +14.45% |
| May, 2025 | $3.1752 | $3.0402 | $8.4715 | -44.59% |
| June, 2025 | $6.9843 | $1.1625 | $7.1643 | +21.89% |
| July, 2025 | $8.7516 | $6.2862 | $10.21 | +52.73% |
| August, 2025 | $4.0689 | $3.569 | $8.4735 | -28.99% |
| September, 2025 | $5.9781 | $1.1108 | $6.8563 | +4.33% |
| October, 2025 | $6.9554 | $4.2917 | $8.7599 | +21.39% |
| November, 2025 | $7.8027 | $6.9522 | $9.4626 | +36.17% |
| December, 2025 | $5.0618 | $3.3618 | $11.70 | -11.66% |
Foghorn Therapeutics Inc Stock (FHTX) Price Forecast for 2026
The predicted value for Foghorn Therapeutics Inc (FHTX) in 2026 is set at an average of $2.6851. Estimates vary from a peak of $5.3037 to a trough of $0.0666, indicating an -53.14% surge from the present price of $5.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.3691 | $2.1991 | $5.3037 | -58.65% |
| February, 2026 | $1.3064 | $1.1364 | $3.0517 | -77.20% |
| March, 2026 | $2.5356 | $0.9383 | $3.5856 | -55.75% |
| April, 2026 | $1.3529 | $0.4911 | $3.5974 | -76.39% |
| May, 2026 | $0.6902 | $0.1216 | $1.5829 | -87.95% |
| June, 2026 | $3.0693 | $0.327 | $4.2238 | -46.43% |
| July, 2026 | $0.2466 | $0.1566 | $3.8512 | -95.70% |
| August, 2026 | $0.5042 | $0.1885 | $0.9403 | -91.20% |
| September, 2026 | $1.6031 | $0.4694 | $2.4213 | -72.02% |
| October, 2026 | $1.9904 | $0.0666 | $2.2917 | -65.26% |
| November, 2026 | $4.0095 | $1.0422 | $4.1295 | -30.03% |
| December, 2026 | $3.0968 | $1.805 | $4.4513 | -45.95% |
Foghorn Therapeutics Inc Stock (FHTX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Foghorn Therapeutics Inc (FHTX) is $4.6618, with a high forecast of $9.3106 and a low forecast of $0.013. This indicates an -18.64% decrease from the last price of $5.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $4.6341 | $2.8605 | $5.2223 | -19.12% |
| February, 2027 | $3.1214 | $2.2397 | $5.4578 | -45.52% |
| March, 2027 | $0.7106 | $0.6906 | $3.5551 | -87.60% |
| April, 2027 | $0.8121 | $0.2776 | $0.7621 | -85.83% |
| May, 2027 | $0.357 | $0.013 | $0.557 | -93.77% |
| June, 2027 | $1.4143 | $0.0389 | $2.1225 | -75.32% |
| July, 2027 | $2.3427 | $1.1662 | $3.0263 | -59.12% |
| August, 2027 | $6.4856 | $0.4154 | $9.3106 | +13.19% |
| September, 2027 | $0.8202 | $0.1997 | $7.7492 | -85.69% |
| October, 2027 | $1.5652 | $0.0338 | $6.5275 | -72.68% |
| November, 2027 | $2.0069 | $3.1579 | $4.1906 | -64.98% |
| December, 2027 | $5.5823 | $5.3796 | $4.3419 | -2.58% |
Foghorn Therapeutics Inc Stock (FHTX) Price Forecast for 2028
In 2028, Foghorn Therapeutics Inc (FHTX) is projected to reach an average price of $4.6355, with a high projection of $9.2048 and a low estimate of $0.0662. This indicates an -19.10% fall from the last price of $5.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $7.874 | $6.6087 | $7.304 | +37.42% |
| February, 2028 | $5.4794 | $6.9094 | $6.9004 | -4.37% |
| March, 2028 | $6.8548 | $6.8793 | $6.3685 | +19.63% |
| April, 2028 | $7.7202 | $7.2212 | $6.9502 | +34.73% |
| May, 2028 | $3.4919 | $4.7819 | $7.4565 | -39.06% |
| June, 2028 | $2.0173 | $3.4373 | $2.4936 | -64.79% |
| July, 2028 | $3.199 | $2.34 | $2.979 | -44.17% |
| August, 2028 | $1.9644 | $2.6281 | $2.1354 | -65.72% |
| September, 2028 | $3.3998 | $4.3758 | $3.2535 | -40.67% |
| October, 2028 | $2.5385 | $0.0662 | $9.2048 | -55.70% |
| November, 2028 | $1.1969 | $0.2179 | $3.2721 | -79.11% |
| December, 2028 | $4.9523 | $2.0133 | $4.2323 | -13.57% |
Foghorn Therapeutics Inc Stock (FHTX) Price Forecast for 2029
The 2029 price forecast for Foghorn Therapeutics Inc Stock (FHTX) is $2.6676 on average, with a high prediction of $5.2764 and a low estimate of $0.0589. This represents an -53.44% decrease from the previous price of $5.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.986 | $0.154 | $4.1987 | -82.79% |
| February, 2029 | $1.3194 | $0.0589 | $3.1483 | -76.97% |
| March, 2029 | $0.2148 | $2.8808 | $2.9885 | -96.25% |
| April, 2029 | $1.4565 | $0.8602 | $2.0198 | -74.58% |
| May, 2029 | $2.3481 | $0.3394 | $2.4281 | -59.02% |
| June, 2029 | $3.7427 | $0.789 | $3.7727 | -34.68% |
| July, 2029 | $2.579 | $2.635 | $5.2764 | -54.99% |
| August, 2029 | $3.7544 | $2.8754 | $3.4181 | -34.48% |
| September, 2029 | $3.9298 | $4.3008 | $3.7235 | -31.42% |
| October, 2029 | $4.3215 | $3.7225 | $3.3129 | -24.58% |
| November, 2029 | $4.9469 | $5.2325 | $4.5969 | -13.67% |
| December, 2029 | $3.3186 | $3.8186 | $4.8433 | -42.08% |
Foghorn Therapeutics Inc Stock (FHTX) Price Forecast for 2030
Foghorn Therapeutics Inc Stock (FHTX) is expected to reach an average price of $2.7183 in 2030, with a high forecast of $5.4085 and a low forecast of $0.0281. This signifies an -52.56% decrease from the last price of $5.73.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $3.524 | $2.6413 | $2.445 | -38.50% |
| February, 2030 | $4.8794 | $5.1204 | $4.7231 | -14.84% |
| March, 2030 | $4.2248 | $5.8441 | $5.4085 | -26.27% |
| April, 2030 | $4.0565 | $3.6238 | $4.0711 | -29.21% |
| May, 2030 | $3.5619 | $3.7792 | $3.6529 | -37.84% |
| June, 2030 | $0.9473 | $1.4473 | $2.6883 | -83.47% |
| July, 2030 | $0.239 | $1.6027 | $1.59 | -95.83% |
| August, 2030 | $1.1244 | $0.0281 | $0.9456 | -80.38% |
| September, 2030 | $2.1961 | $1.3335 | $1.1208 | -61.67% |
| October, 2030 | $4.9615 | $2.9625 | $4.0615 | -13.41% |
| November, 2030 | $4.3669 | $4.9959 | $4.9242 | -23.79% |
| December, 2030 | $3.3886 | $3.7386 | $4.1333 | -40.86% |
1.51%
Cap:
|
Volume (24h):